Healthcare Equipment and Supplies
Company Overview of CareDx, Inc
CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA ...
3260 Bayshore Boulevard
Brisbane, CA 94005
Founded in 1998
Key Executives for CareDx, Inc
Chief Executive Officer
Total Annual Compensation: $350.0K
Chief Medical Officer and Executive Vice President
Total Annual Compensation: $365.7K
Chief Compliance Officer and Chief Business Officer
Total Annual Compensation: $308.3K
Compensation as of Fiscal Year 2013.
CareDx, Inc Key Developments
CareDx, Inc(NasdaqGM:CDNA) added to NASDAQ Composite Index
Jul 18 14
CareDx, Inc will be added to the NASDAQ Composite Index.
CareDx Seeks Acquisitions
Jun 3 14
CareDx, Inc. has filed an IPO in the amount of $50 million. CareDx intends to use the net proceeds from offering for research and development, including research aimed at expanding the clinical utility of AlloMap and the development of new solutions for the surveillance of heart and kidney transplant recipients, for sales and marketing activities, including expansion of our sales force to support the ongoing commercialization of our products and remainder for general and administrative expenses (including personnel related costs and the costs of operating as a public company), and for working capital and other general corporate purposes. CareDx may also use a portion of the net proceeds from this offering for the acquisition of, or investment in, technologies, solutions or businesses that complement our business.
XDx, Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-11-2014 11:45 AM
Dec 19 13
XDx, Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-11-2014 11:45 AM. Venue: The Waldorf-Astoria Hotel, Conrad Room, New York, New York, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries